Giovanni Caforio

Chairman and CEO of Bristol-Myers Squibb, Caforio is a medical innovator focused on advancing treatments in oncology, immunology, and cardiovascular diseases.

Explore Giovanni Caforio's largest investments on Profit.com, including companies like Bristol-Myers Squibb Company, Stryker Corporation, and their significance in his portfolio.

Giovanni Caforio’s portfolio updates are typically published quarterly through SEC 13F filings, which provide detailed information about their holdings, including recent buys and sells. Additionally, real-time updates on insider trades are available through Form 4 filings, offering a more timely view of their trading activity.

Giovanni Caforio currently invests in companies such as Bristol-Myers Squibb Company, Stryker Corporation, focusing on sectors like Healthcare.

The largest holding in Giovanni Caforio’s portfolio is Bristol-Myers Squibb Company, accounting for 98.18% of their total investments.

One of Giovanni Caforio’s most profitable investments is Bristol-Myers Squibb Company, which has generated a return of 37.03% over the past year.

As of 28 Sep 2026, Giovanni Caforio’s portfolio is valued at approximately $27.68M, based on the latest filings available on Profit.com.

Yes, you can use Profit.com to follow Giovanni Caforio’s portfolio and gain insights to build your own investment portfolio.

You can follow Giovanni Caforio’s portfolio updates on Profit.com, which provides notifications on the latest portfolio transactions as soon as they’re available.

Stay up-to-date with Giovanni Caforio’s latest trades by following their portfolio on Profit.com. Enable notifications to receive real-time alerts on their newest buy and sell transactions.